Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers

Year of publication

2019

Authors

Talwelkar, Sarang S.; Nagaraj, Ashwini S.; Devlin, Jennifer R.; Hemmes, Annabrita; Potdar, Swapnil; Kiss, Elina A.; Saharinen, Pipsa; Salmenkivi, Kaisa Maria; Mäyränpää, Mikko I.; Wennerberg, Krister; Verschuren, Emmy

Organizations and authors

University of Helsinki

Hemmes Annabrita

Nagaraj Ashwini S.

Kiss Elina A.

Verschuren Emmy

Devlin Jennifer R.

Salmenkivi Kaisa Maria

Wennerberg Krister

Mäyränpää Mikko I.

Saharinen Pipsa

Talwelkar Sarang S.

Potdar Swapnil

Helsinki University Hospital

Hemmes Annabrita

Nagaraj Ashwini S.

Kiss Elina A.

Verschuren Emmy

Devlin Jennifer R.

Salmenkivi Kaisa Maria

Wennerberg Krister

Mäyränpää Mikko I.

Saharinen Pipsa

Talwelkar Sarang S.

Potdar Swapnil

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

Molecular cancer therapeutics

Parent publication name

Molecular Cancer Therapeutics

Volume

Issue

Pages

1863-1874

ISSN

1538-8514

Publication forum

63518

Publication forum level

Open access

Open access in the publisher’s service

Self-archived

Yes

Other information

Fields of science

Cancers

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

United States

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

DOI

10.1158/1535-7163.MCT-18-0573

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes